A chromosome 3-encoded repressor of the Human Telomerase Reverse Transcriptase (hTERT) gene controls of the state of hTERT chromatin

Cancer Research

Volumn 63, Issue 3, 2003, Pages 689-695

  Szutorisz, Henrietta ^a   Lingner, Joachim ^a   Cuthbert, Andrew P ^b,c   Trott, Deborah A ^b,d   Newbold, Robert F ^b   Nabholz, Markus ^a  

^a SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

^b BRUNEL UNIVERSITY   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d MRC CLINICAL SCIENCES CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RNA DIRECTED DNA POLYMERASE; TELOMERASE REVERSE TRANCRIPTASE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CARCINOGENESIS; CHROMATIN; CHROMOSOME 3; CHROMOSOME MAP; ENZYME ACTIVITY; ENZYME REGULATION; GENE CONTROL; GENE FUNCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REPRESSOR GENE; TRANSCRIPTION REGULATION;

CHROMATIN; CHROMOSOMES, HUMAN, PAIR 3; DNA-BINDING PROTEINS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRONS; MICROCOCCAL NUCLEASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TELOMERASE; TUMOR CELLS, CULTURED;

EID: 0037310397     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley. C. B., West, M. D., Ho, P. L., Coviello, G. M., Wright, W. E., Weinrich, S. L., and Shay, J. W. Specific association of human telomerase activity with immortal cells and cancer. Science (Wash. DC), 266: 2011-2015, 1994.
2. Henson, J. D., Neumann, A. A., Yeager, T. R., and Reddel, R. R. Alternative lengthening of telomeres in mammalian cells. Oncogene, 21: 598-610, 2002.
3. Chen. J. L., Blasco, M. A., and Greider, C. W. Secondary structure of vertebrate telomerase RNA. Cell, 100: 503-514, 2000.
4. Feng, J., Funk, W. D., Wang, S. S., Weinrich, S. L., Avilion, A. A., Chiu. C. P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., et al. The RNA component of human telomerase. Science (Wash. DC), 269; 1236-1241, 1995.
5. Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., and Cech, T. R. Telomerase catalytic subunit homologs from fission yeast and human. Science (Wash. DC), 277: 955-959, 1997.
6. Meyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L. W., Steiner, P., Caddle, S. D., Ziaugra, L., Beijersbergen, R. L., Davidoff, M. J., Liu, Q., Bacchetti, S., Haber, D. A., and Weinberg, R. A. hEST2, the putative human telomerase catalytic subunit gene, is un-regulated in tumor cells and during immortalization. Cell. 90: 785-795, 1997.
7. Bodnar. A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C. P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., and Wright. W. E. Extension of life-span by introduction of telomerase into normal human cells. Science (Wash. DC), 279: 349-352, 1998.
8. Yang, J., Chang, E., Cherry, A. M., Bangs. C. D., Oei, Y., Bodnar, A., Bronstein, A., Chiu. C. P., and Herron, G. S. Human endothelial cell life extension by telomerase expression. J. Biol. Chem., 274: 26141-26148, 1999.
9. Vaziri, H., and Benchimol, S. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr. Biol., 8: 279-282, 1998.
10. Migliaccio, M., Amacker. M., Just, T., Reichenbach, P., Valmori, D., Cerottini, J. C., Romero, P., and Nabholz, M. Ectopic human telomerase catalytic subunit expression maintains telomere length but is not sufficient for CD8+ T lymphocyte immortalization. J. Immunol., 165: 4978-4984, 2000.
11. Ducrest. A. L., Szutorisz, H., Lingner. J., and Nabholz, M. Regulation of the human telomerase reverse transcriptase gene. Oncogene, 21: 541-552, 2002.
12. Oshimura, M., and Barrett. J. C. Multiple pathways to cellular senescence: role of telomerase repressors. Eur. J. Cancer, 33: 710-715, 1997.
13. Cuthbert, A. P., Bond, J., Trott, D. A., Gill, S., Broni, J., Marriott, A., Khoudoli, G., Parkinson, E. K., Cooper, C. S., and Newbold, R. F. Telomerase repressor sequences on chromosome 3 and induction of permanent growth arrest in human breast cancer cells. J. Natl. Cancer Inst. (Bethesda), 91: 37-45, 1999.
14. Backsch. C., Wagenbach, N., Nonn, M., Leistritz, S., Stanbridge. E., Schneider, A., and Durst, M. Microcell-mediated transfer of chromosome 4 into HeLa cells suppresses telomerase activity. Genes Chromosomes Cancer, 31: 196-198. 2001.
15. Horikawa, I., Oshimura, M., and Barrett, J. C. Repression of the telomerase catalytic subunit by a gene on human chromosome 3 that induces cellular senescence. Mol. Carcinog., 22: 65-72, 1998.
16. Tanaka, H., Shimizu, M., Horikawa, I., Kugoh, H., Yokota, J., Barrett, J. C., and Oshimura, M. Evidence for a putative telomerase repressor gene in the 3p14.2-p21. I region. Genes Chromosomes Cancer, 23: 123-133. 1998.
17. Cuthbert, A. P., Trott, D. A., Ekong, R. M., Jezzard, S., England, N. L., Themis, M., Todd, C. M., and Newbold, R. F. Construction and characterization of a highly stable human: rodent monochromosomal hybrid panel for genetic complementation and genome mapping studies. Cytogenet. Cell Genet., 71: 68-76. 1995.
18. Cong, Y. S., Wen, J., and Bacchetti, S. The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. Hum. Mol. Genet., 8: 137-142, 1999.
19. Horikawa, I., Cable, P. L., Afshari, C., and Barrett, J. C. Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Res., 59: 826- 830, 1999.
20. Kyo, S., Takakura, M., Taira, T., Kanaya, T., Itoh, H., Yutsudo, M., Ariga, H., and Inoue, M. SpI cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Nucleic Acids Res., 28: 669-677. 2000.
21. Crowe, D. L., Nguyen, D. C., Tsang. K. J., and Kyo, S. E2F-1 represses transcription of the human telomerase reverse transcriptase gene. Nucleic Acids Res., 29: 2789-2794, 2001.
22. Braunstein. I., Cohen-Barak, O., Shachaf, C., Ravel, Y., Yalon-Hacohen, M., Mills, G. B., Tzukerman, M., and Skorecki, K. L. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells. Cancer Res., 61: 5529-5536, 2001.
23. Tzukerman, M., Shachaf, C., Ravel, Y., Braunstein, I., Cohen-Barak. O., YalonHacohen, M., and Skorecki, K. L. Identification of a novel transcription factor binding element involved in the regulation by differentiation of the human telomerase (hTERT) promoter. Mol. Biol. Cell., 11, 4381-4391. 2000.
24. Ducrest, A. L., Amacker, M., Mathieu, Y. D., Cuthbert, A. P., Trott, D. A., Newbold. R. F., Nabholz, M., and Lingner, J. Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity. Cancer Res., 61: 7594-7602, 2001.
25. Gregory, P. D., and Horz, W. Mapping chromatin structure in yeast. Methods Enzymol., 304: 365-376, 1999.
26. Wallrath, L. L., Lu, Q., Granok, H., and Elgin, S. C. Architectural variations of inducible eukaryotic promoters: preset and remodeling chromatin structures. Bioessays, 16: 165-170, 1994.
27. Mirkovitch, J., Decker, T., and Darnell, J. E., Jr. Interferon induction of gene transcription analyzed by in vivo footprinting. Mol. Cell. Biol., 12: 1-9, 1992.
28. Church, G. M., and Gilbert, W. Genomic sequencing. Proc. Natl. Acad. Sci. USA, 81: 1991-1995, 1984.
29. Perrem, K., Bryan, T. M., Englezou, A., Hackl, T., Moy, E. L., and Reddel, R. R. Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids. Oncogene, 18: 3383-3390, 1999.
30. Wu, K. J., Grandori, C., Amacker, M., Simon-Vermot, N., Polack, A., Lingner, J., and Dalla-Favera, R. Direct activation of TERT transcription by c-MYC. Nat. Genet., 21: 220-224, 1999.
31. Greenberg, R. A., O'Hagan, R. C., Deng, H., Xiao, Q., Hann, S. R., Adams, R. R., Lichtsteiner, S., Chin, L., Morin, G. B., and DePinho, R. A. Telomerase reverse trangcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene, 18: 1219-1226, 1999.
32. Gunes, C., Lichtsteiner, S., Vasserot, A. P., and Englert, C. Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Madl. Cancer Res., 60: 2116-2121, 2000.
33. Oh, S., Song, Y. H., Yim, J., and Kim, T. K. Identification of Mad as a repressor of the human telomerase (hTERT) gene. Oncogene, 19: 1485-1490, 2000.
34. Huebner, K., Garrison, P. N., Barnes, L. D., and Croce, C. M. The role of the FHIT/FRA3B locus in cancer. Annu. Rev. Genet., 32: 7-31, 1998.
35. Baur, J. A., Zou, Y., Shay, J. W., and Wright, W. E. Telomere position effect in human cells. Science (Wash. DC), 292: 2075-2077, 2001.
36. Leem, S. H., Londono-Vallejo, J. A., Kim, J. H., Bui, H., Tubacher, E., Solomon, G., Park, J. E., Horikawa, I., Kouprina, N., Barrett, J. C., and Larionov, V. The human telomerase gene: complete genomic sequence and analysis of tandem repeat polymorphisms in intronic regions. Oncogene, 21: 769-777, 2002.
37. Misiti, S., Nanni, S., Fontemaggi, G., Cong, Y. S., Wen, J., Hirte, H. W., Piaggio, G., Sacchi, A., Pontecorvi, A., Bacchetti, S., and Farsetti, A. Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cells. Mol. Cell. Biol., 20: 3764-3771, 2000.
38. Xu, D., Popov, N., Hou, M., Wang, Q., Bjorkholm, M., Gruber, A., Menkel, A. R., and Henriksson, M. Switch from Myc/Max to Madl/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells. Proc. Natl. Acad. Sci. USA, 98: 3826-3831, 2001.
39. Himes, S. R., Tagoh, H., Goonetilleke, N., Sasmono, T., Oceandy, D., Clark, R., Bonifer, C., and Hume, D. A. A highly conserved c-fms gene intronic element controls macrophage-specific and regulated expression. J. Leukoc. Biol., 70: 812-820, 2001.
40. Rowntree, R. K., Vassaux, G., McDowell, T. L., Howe, S., McGuigan, A., Phylactides, M., Huxley, C., and Harris, A. An element in intron 1 of the CFTR gene augments intestinal expression in vivo. Hum. Mol. Genet., 10: 1455-1464, 2001.
41. Schick, B. P., Petrushina, I., Brodbeck, K. C., and Castronuevo, P. Promoter regulatory elements and DNaseI-hypersensitive sites involved in serglycin proteoglycan gene expression in human erythroleukemia, CHRF 288-11, and HL-60 cells. J. Biol. Chem., 276: 24726-24735, 2001.
42. Smith, D. J., Nuthall, H. N., Majetti, M. E., and Harris, A. Multiple potential intragenic regulatory elements in the CFTR gene. Genomics, 64: 90-96, 2000.
43. Frank, S. R., Schroeder, M., Fernandez, P., Taubert, S., and Amati, B. Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Genes Dev., 15: 2069-2082, 2001.
44. Bungert, J., Tanimoto, K., Patel, S., Liu, Q., Fear, M., and Engel, J. D. Hypersensitive site 2 specifies a unique function within the human β-globin locus control region to stimulate globin gene transcription. Mol. Cell. Biol., 19: 3062-3072, 1999.
45. Wood. J. G., and Sinclair, D. A. TPE or not TPE? It's no longer a question. Trends Pharmacol. Sci., 23: 1-4, 2002.
46. Szutorisz, H., Palmqvist, R., Roos, G., Stenling, R., Schorderet, D. F., Reddel, R., Lingner, J., and Nabholz, M. Rearrangements of minisatellites in the human telomerase reverse transcriptase gene are not correlated with its expression in colon carcinomas. Oncogene. 20: 2600-2605, 2001.